Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Analysis on reasons for discontinuation of sglt2i in type 2 diabetes mellitus patients in taiwan

  • At: 2018 FIP Congress in Glasgow (Scotland)
  • Type: Poster
  • By: LIN, Yi-Han (Chang Gung Memorial Hospital, Keelung, Taiwan, Department of Pharmacy)
  • Co-author(s): Yi-Han Lin: Department of Pharmacy, Chang Gung Memorial Hospital, Keelung, Taiwan, Keelung city, Taiwan, Province of China
    Shih-Chieh Shao: Department of Pharmacy, Chang Gung Memorial Hospital, Keelung, Taiwan, Keelung city, Taiwan, Province of China;School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan city, Taiwan, Province of China
    Yuk-Ying Chan: Department of Pharmacy, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan, Province of China
    Hui-Yu Chen: Department of Pharmacy, Chang Gung Memorial Hospital, Keelung, Taiwan, Keelung city, Taiwan, Province of China
  • Abstract:

    Background

    Adherence on glucose co-transporter 2 inhibitors (SGLT2i) is the primary issue for type 2 diabetes mellitus (T2DM) patients in real-world settings. Understanding the reasons for discontinuations is crucial for successful strategies to improve treatment outcome.

    Methods

    We conducted a cohort study and analyzed the data of three hospitals in

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 13 May 2019

FIP Congresses